Literature DB >> 25311294

Assessing decentering: validation, psychometric properties, and clinical usefulness of the Experiences Questionnaire in a Spanish sample.

Joaquim Soler1, Alba Franquesa2, Albert Feliu-Soler3, Ausias Cebolla4, Javier García-Campayo5, Rosa Tejedor6, Marcelo Demarzo7, Rosa Baños8, Juan Carlos Pascual3, Maria J Portella3.   

Abstract

Decentering is defined as the ability to observe one's thoughts and feelings in a detached manner. The Experiences Questionnaire (EQ) is a self-report instrument that originally assessed decentering and rumination. The purpose of this study was to evaluate the psychometric properties of the Spanish version of EQ-Decentering and to explore its clinical usefulness. The 11-item EQ-Decentering subscale was translated into Spanish and psychometric properties were examined in a sample of 921 adult individuals, 231 with psychiatric disorders and 690 without. The subsample of nonpsychiatric participants was also split according to their previous meditative experience (meditative participants, n=341; and nonmeditative participants, n=349). Additionally, differences among these three subgroups were explored to determine clinical validity of the scale. Finally, EQ-Decentering was administered twice in a group of borderline personality disorder, before and after a 10-week mindfulness intervention. Confirmatory factor analysis indicated acceptable model fit, sbχ(2)=243.8836 (p<.001), CFI=.939, GFI=.936, SRMR=.040, and RMSEA=.06 (.060-.077), and psychometric properties were found to be satisfactory (reliability: Cronbach's α=.893; convergent validity: r>.46; and divergent validity: r<-.35). The scale detected changes in decentering after a 10-session intervention in mindfulness (t=-4.692, p<.00001). Differences among groups were significant (F=134.8, p<.000001), where psychiatric participants showed the lowest scores compared to nonpsychiatric meditative and nonmeditative participants. The Spanish version of the EQ-Decentering is a valid and reliable instrument to assess decentering either in clinical and nonclinical samples. In addition, the findings show that EQ-Decentering seems an adequate outcome instrument to detect changes after mindfulness-based interventions.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Experiences Questionnaire; decentering; metacognitive awareness; mindfulness

Mesh:

Year:  2014        PMID: 25311294     DOI: 10.1016/j.beth.2014.05.004

Source DB:  PubMed          Journal:  Behav Ther        ISSN: 0005-7894


  16 in total

1.  A mindfulness training program based on brief practices (M-PBI) to reduce stress in the workplace: a randomised controlled pilot study.

Authors:  M Arredondo; M Sabaté; N Valveny; M Langa; R Dosantos; J Moreno; L Botella
Journal:  Int J Occup Environ Health       Date:  2017-10-30

2.  Predicting Non-Suicidal Self-Injury in Young Adults with and without Borderline Personality Disorder: a Multilevel Approach Combining Ecological Momentary Assessment and Self-Report Measures.

Authors:  Laia Briones-Buixassa; Ítalo Alí; Carlos Schmidt; Stella Nicolaou; Juan Carlos Pascual; Joaquim Soler; Daniel Vega
Journal:  Psychiatr Q       Date:  2021-01-21

3.  Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States.

Authors:  Otto Simonsson; Simon B Goldberg
Journal:  J Psychoactive Drugs       Date:  2022-01-09

4.  Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities.

Authors:  Joaquim Soler; Matilde Elices; Alba Franquesa; Steven Barker; Pablo Friedlander; Amanda Feilding; Juan C Pascual; Jordi Riba
Journal:  Psychopharmacology (Berl)       Date:  2015-11-27       Impact factor: 4.530

5.  The serenity of the meditating mind: a cross-cultural psychometric study on a two-factor higher order structure of mindfulness, its effects, and mechanisms related to mental health among experienced meditators.

Authors:  Ulrich S Tran; Ausiàs Cebolla; Tobias M Glück; Joaquim Soler; Javier Garcia-Campayo; Theresa von Moy
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

6.  Psychological Effects of a 1-Month Meditation Retreat on Experienced Meditators: The Role of Non-attachment.

Authors:  Jesus Montero-Marin; Marta Puebla-Guedea; Paola Herrera-Mercadal; Ausias Cebolla; Joaquim Soler; Marcelo Demarzo; Carmelo Vazquez; Fernando Rodríguez-Bornaetxea; Javier García-Campayo
Journal:  Front Psychol       Date:  2016-12-12

7.  Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities.

Authors:  Frederic Sampedro; Mario de la Fuente Revenga; Marta Valle; Natalia Roberto; Elisabet Domínguez-Clavé; Matilde Elices; Luís Eduardo Luna; José Alexandre S Crippa; Jaime E C Hallak; Draulio B de Araujo; Pablo Friedlander; Steven A Barker; Enrique Álvarez; Joaquim Soler; Juan C Pascual; Amanda Feilding; Jordi Riba
Journal:  Int J Neuropsychopharmacol       Date:  2017-09-01       Impact factor: 5.176

8.  Combining emotion regulation and mindfulness skills for preventing depression relapse: a randomized-controlled study.

Authors:  Matilde Elices; Joaquim Soler; Albert Feliu-Soler; Cristina Carmona; Thais Tiana; Juan C Pascual; Azucena García-Palacios; Enric Álvarez
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2017-07-05

9.  Exploring the relation between childhood trauma, temperamental traits and mindfulness in borderline personality disorder.

Authors:  Matilde Elices; Juan C Pascual; Cristina Carmona; Ana Martín-Blanco; Albert Feliu-Soler; Elisabet Ruiz; Montserrat Gomà-I-Freixanet; Víctor Pérez; Joaquim Soler
Journal:  BMC Psychiatry       Date:  2015-07-29       Impact factor: 3.630

10.  Four Weekly Ayahuasca Sessions Lead to Increases in "Acceptance" Capacities: A Comparison Study With a Standard 8-Week Mindfulness Training Program.

Authors:  Joaquim Soler; Matilde Elices; Elisabeth Dominguez-Clavé; Juan C Pascual; Amanda Feilding; Mayte Navarro-Gil; Javier García-Campayo; Jordi Riba
Journal:  Front Pharmacol       Date:  2018-03-20       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.